4 results
PRE 14A
ABOS
Acumen Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
4:33pm
of the Board’s self-evaluation, which is conducted periodically. In the case of new director candidates, the Nominating and Corporate Governance Committee
DEF 14A
ABOS
Acumen Pharmaceuticals Inc
27 Apr 22
Definitive proxy
5:03pm
the directors’ independence. The Committee also takes into account the results of the Board’s self-evaluation, which is conducted periodically. In the case
- Prev
- 1
- Next